Jefferies Upgrades Eli Lilly To Buy

Analysts at Jefferies upgraded

from Hold to Buy. The price target for Eli Lilly has been raised from $75 to $80. Eli Lilly shares have jumped 33.96% over the past 52 weeks, while the S&P 500 index has gained 10.22% in the same period. Eli Lilly's shares fell 0.70% to close at $69.23 yesterday.